Two-part, cyanoacrylate/cationically curable adhesive systems
US-8981027-B2 · Mar 17, 2015 · US
US12103997B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12103997-B2 |
| Application number | US-202117158989-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 26, 2021 |
| Priority date | Aug 13, 2018 |
| Publication date | Oct 1, 2024 |
| Grant date | Oct 1, 2024 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Two-part cyanoacrylate/cationically curable adhesive systems are provided.
Opening claim text (preview).
The invention claimed is: 1. A two-part curable composition comprising: a. a first part comprising a cyanoacrylate component, and a cationic curing catalyst; b. a second part comprising a cationic curable component, an initiator component, and a cyclic carbonate; wherein the two-part composition further comprises core-shell rubber particles having an average particle size of from about 50 μm to about 300 μm; wherein when mixed together, the cationic curing catalyst initiates cure of the cationic curable component. 2. The composition of claim 1 , wherein the cyclic carbonate has the following structure: n is 1 to 3; each R is independently selected from hydrogen, C 1 -C 12 aliphatic, or C 3 -C 10 cycloaliphatic; or together at least two R form a ring system comprising from 4 to 12 carbon atoms, said ring system optionally including one or more nitrogen, oxygen or sulfur atoms; each R can independently be unsubstituted or substituted with at least one of a halogen, a hydroxyl, an amino group, a sulfonyl group, a sulphonamide group, a thiol, a C 1 -C 6 alkyl, a C 1 -C 6 alkoxy, a C 1 -C 6 ether, a C 1 -C 6 thioether, a C 1 -C 6 ester, a C 1 -C 6 ketone, a C 1 -C 6 ketimine, a C 1 -C 6 sulfone, a C 1 -C 6 sulfoxide, a C 1 -C 6 primary amide, a C 1 -C 6 secondary amide, a halo C 1 -C 6 alkyl, a carboxyl group, a cyano group, a nitro group, a nitroso group, —C(O)O—C 1 -C 6 alkyl, —OC(O)O—C 1 -C 6 alkyl, —OC(O)NR′R′, —N(R′)C(O)NR′R′, —N(R′)C(O)O—C 1 -C 6 alkyl, oxo, C 3 -C 6 cycloalkyl, C 3 -C 6 heterocyclyl, C 2 -C 5 heteroaryl and C 6 -C 10 aryl; wherein each R′ is independently selected, from the group consisting of hydrogen and C 1 -C 6 alkyl. 3. The composition of claim 2 , wherein n is 1 or 2. 4. The composition of claim 2 , wherein R is C 1 -C 12 aliphatic optionally substituted with one or more hydroxyl, C 1 -C 6 alkyl or C 1 -C 6 alkoxy. 5. The composition of claim 1 , wherein the cyclic carbonate has the following structure: wherein n is 1 or 2, and each R is independently selected from H or C 1 -C 12 aliphatic aliphatic optionally substituted with one or more hydroxyl, C 1 -C 6 alkyl or C 1 -C 6 alkoxy. 6. The composition of claim 1 , wherein the cyclic carbonate has the following structure: wherein R is selected from H or C 1 -C 12 aliphatic aliphatic optionally substituted with one or more hydroxyl, C 1 -C 6 alkyl or C 1 -C 6 alkoxy. 7. The composition of claim 6 , where R is C 1 -C 12 alkyl optionally substituted with one or more hydroxyl, C 1 -C 6 alkyl or C 1 -C 6 alkoxy. 8. The composition of claim 1 , wherein the cyclic carbonate is present in an amount of from about 5 wt % to about 35 wt % based on the total weight of the second part, based on the total weight of the second part. 9. The composition of claim 1 , wherein the cyclic carbonate is a liquid at room temperature. 10. The composition of claim 1 , wherein the core-shell rubber particles comprise acrylonitrile butadiene-styrene copolymer and/or methyl methacrylate butadiene styrene copolymer. 11. The composition of claim 1 , wherein the core-shell rubber particles are present in an amount of from about 10 wt % to 15 wt %, in the second part of the composition, based on the total weight of the second part of the composition. 12. The composition of claim 1 , further comprising a thermoplastic resin. 13. The composition of claim 12 , wherein the thermoplastic resin comprises a thermoplastic acrylic resin. 14. The composition of claim 12 , wherein the thermoplastic resin is composed of a methyl methacrylate and butyl methacrylate copolymer. 15. The composition of claim 12 , wherein the thermoplastic resin is present in an amount of from about 1.5 wt % to about 15 wt % based on the total weight of the composition. 16. The composition of claim 12 , wherein the thermoplastic resin is present in an amount of from about 5 wt % to about 15 wt % based on the total weight of the second part. 17. The composition of claim 1 , wherein the cyanoacrylate component comprises H 2 C═C(CN)—COOR, wherein R is selected from alkyl, alkoxyalkyl, cycloalkyl, alkenyl, aralkyl, aryl, allyl and haloalkyl groups. 18. The composition of claim 1 , wherein the cationic curing catalyst comprises salts of lithium and metals from Group II of the Periodic Table, and non-nucleophilic acids. 19. The composition of claim 1 , wherein the cationic curing catalyst is a non-nucleophilic acid having a pH of less than 1.0 when measured as a 10% by weight solution in water. 20. The composition of claim 1 , wherein the cationic curing catalyst is a member selected from the group consisting of fluoroboric, fluoroarsenic, fluoroantimonic and fluorophosphoric acids; lithium tetrafluoroborate, calcium di-tetrafluoroborate, magnesium di-tetrafluoroborate, lithium hexaflourophosphate, calcium di-hexaflourophosphate, magnesium di-hexaflourophosphate, lithium hexaflouroantimonate and lithium hexaflouroarsenate; lanthanide triflate salts, aryl iodonium salts, aryl sulfonium salts, lanthanum triflate, ytterbium triflate, trimethoxyboroxine, trimethoxyboroxine-aluminum acetyl acetonate, amine-boron trihalide complexes, quaternary ammonium salts, quaternary phosphonium salts, tri-aryl sulfonium salts, di-aryl iodonium salts, and diazonium salts; trialkoxyboroxine curing agents; and combinations thereof. 21. The composition of claim 1 , wherein the cationic curable component is selected from an epoxy component, an episulfide component, an oxetane component, a vinyl ether component and combinations thereof. 22. The composition of claim 1 , wherein the cationic curable component is an epoxy component selected from the group consisting of cycloaliphatic epoxy, aromatic epoxy, aliphatic epoxy and hydrogenated aromatic epoxy. 23. The composition of claim 22 , wherein the epoxy component comprises a cycloaliphatic epoxy selected from the group consisting of: 2-(3,4-epoxy)cyclohexyl-5,5-spiro-(3,4-epoxy)cyclohexane-m-dioxane, 3,4-epoxycyclohexylmethyl-3,4-epoxycyclohexanecarboxylate,3,4-epoxy-6-methylcyclohexylnnethyl-3,4-epoxy-6-methylcyclohexanecarboxylate, vinyl cyclohexanedioxide, bis(3,4-epoxycyclohexylmethyl)adipate, bis(3,4-epoxy-6-methylcyclohexylmethyl)adipate, exo-exo bis(2,3-epoxycyclopentyl) ether, endo-exo bis(2,3-epoxycyclopentyl) ether, 2,2-bis(4-(2,3-epoxypropoxy)cyclohexyl)propane, 2,6-bis(2,3-epoxypropoxycyclohexyl-p-dioxane), 2,6-bis(2,3-epoxypropoxy)norbornene. 24. The composition of claim 22 , wherein the epoxy component is a member selected from the group consisting of epoxy-functionalized hydrogenated bisphenol-A, bisphenol-F, bisphenol-E, bisphenol-S and biphenyl. 25. The composition of claim 1 , wherein the first part is housed in a first chamber of a dual chamber syringe and the second part is housed in a second chamber of the dual chamber syringe. 26. The composition of claim 1 , wherein the first part further comprises phosphoric acid. 27. The composition of claim 1 , wherein the second part further comprises at least one of a plasticizer, a filler and a toughener.
{Organic non-macromolecular compounds having at least one polymerisable carbon-to-carbon unsaturated bond} in combination with a macromolecular compound other than an unsaturated polymer of groups C09J159/00 - C09J187/00 · CPC title
Core-shell polymer · CPC title
ABS [Acrylonitrile-Butadiene-Styrene] polymers · CPC title
with conjugated dienes · CPC title
Additives being defined by their particle size in general · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.